Drug intelligence / Profile preview

sodium orthovanadate

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Sodium orthovanadate is an inorganic salt and a potent, broad-spectrum inhibitor of protein tyrosine phosphatases (PTPs). By acting as a phosphate mimetic, it prevents the dephosphorylation of tyrosine residues on various proteins, thereby prolonging and intensifying intracellular signaling pathways. In the context of oncology research, it has been shown to inhibit the proliferation of cancer cells, including prostate cancer models like DU-145, by inducing apoptosis and necrosis and triggering cell cycle arrest at the G1/S checkpoint. Beyond its potential as an antineoplastic agent, sodium orthovanadate is recognized for its insulin-mimetic properties and is a standard laboratory reagent used in molecular biology to preserve the phosphorylation state of proteins in cell lysates.

Other names
Na3VO4Na-3VO4Na 3VO4trisodium orthovanadatesodium vanadate (V)
02

Targets

ALPP (Alkaline phosphatase, placental type)IP3R (Inositol Trisphosphate Receptor)

Beyond the preview

Go deeper on sodium orthovanadate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium orthovanadate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call